Our Opinion

Cyteir Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company mentioned on its website that they use animals for product testing.

“Preclinical studies to date have demonstrated Cyteir’s lead RAD51 modulator to be potent, highly selective for AID-positive cells, effective against cancer cells in vitro and in vivo, and well tolerated in preclinical animal models.” Read the following article

Company Description

Cyteir Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing precision oncology medicines that inhibit deoxyribonucleic acid (DNA) damage repair and cause cancer cell death through a therapeutic strategy known as synthetic lethality. The Company’s pipeline includes CYT-0851 and CYT-1853.

Company Website: https://cyteir.com